Reports for CHEPLAPHARM ARZNEIMITTEL GMBH
Company Name
CHEPLAPHARM ARZNEIMITTEL GMBH
Totals |
||
Shortage reports |
48 |
|
| Actual shortage: | 7 (15%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 1 (2%) | |
| Resolved: | 40 (83%) | |
Discontinuation Reports |
7 |
|
| To be discontinued: | 3 (43%) | |
| Discontinued: | 4 (57%) | |
| Reversed: | 0 (0%) | |
Late reports |
4 (7%) |
|
Overdue reports |
4 (40%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ANANDRON | 50MG | TABLET | Actual shortage | 2023-09-14 | 2024-05-16 | 204346 |
| INHIBACE PLUS | 5MG 12.5MG | TABLET | Resolved | 2021-01-04 | 2021-10-19 | 130792 |
| INHIBACE PLUS | 12.5MG 5MG | TABLET | Resolved | 2022-05-09 | 2022-05-25 | 160204 |
| INHIBACE PLUS | 12.5MG 5MG | TABLET | Resolved | 2022-08-17 | 2022-09-30 | 166884 |
| VALCYTE | 450MG | TABLET | Resolved | 2023-05-02 | 2023-05-25 | 191490 |
| VALCYTE | 450MG | TABLET | Resolved | 2023-09-27 | 2023-11-05 | 205325 |
| VALCYTE | 450MG | TABLET | Resolved | 2024-01-04 | 2024-02-01 | 214848 |
| LOSEC MUPS | 20MG | TABLET (DELAYED-RELEASE) | Actual shortage | 2023-12-13 | 2024-04-26 | 213267 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| SUPREFACT DEPOT 2 MONTHS | 6.3MG | IMPLANT | To be discontinued | 2024-05-16 | 2024-05-16 | 228169 |
| SUPREFACT DEPOT 3 MONTHS | 9.45MG | IMPLANT | To be discontinued | 2024-05-16 | 2024-05-16 | 228166 |
| SUPREFACT | 100MCG | SOLUTION | Discontinued | 2021-12-13 | 2021-12-13 | 151039 |
| ANANDRON | 50MG | TABLET | To be discontinued | 2024-05-16 | 2024-05-16 | 228155 |
| XELODA | 150MG | TABLET | Discontinued | 2022-11-30 | 2022-12-01 | 176355 |
| XELODA | 500MG | TABLET | Discontinued | 2022-11-30 | 2022-12-01 | 176359 |
| LOSEC | 20MG | TABLET (DELAYED-RELEASE) | Discontinued | 2021-11-19 | 2021-11-19 | 149669 |
Showing 1 to 7 of 7